Related Experiment Videos

[Rhino-orbito-cerebral mucormycosis]

M Mahi1, S Chaouir, T Amil

  • 1Services d'Imagerie Médicale, Hôpital Militaire d'Instruction Mohamed V, Rabat- Maroc, France. mahi.m@caramail.com

Journal De Radiologie
|April 20, 2002
PubMed

Insights

Rhino-orbito-cerebral mucormycosis, a rare fungal infection, can rapidly invade facial and brain structures, especially in diabetics. Prompt diagnosis and treatment with Amphotericin B, debridement, and diabetes control led to a favorable outcome in a reported case.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Ophthalmology

Background:

  • Rhino-orbito-cerebral mucormycosis is a rare, aggressive fungal infection.
  • It commonly affects individuals with predisposing conditions like diabetes and immunosuppression.
  • The infection rapidly invades the nasal cavity, sinuses, orbits, and intracranial structures.

Observation:

  • A diabetic patient presented with extensive facial necrotic lesions.
  • Initial treatment with antistaphylococcic therapy was ineffective.
  • Diagnosis was confirmed through histologic and mycologic examinations.

Findings:

  • The patient was successfully treated with Amphotericin B.
  • Daily surgical debridement was a crucial part of the treatment regimen.
  • Optimal control of the patient's diabetes was essential for recovery.

Implications:

  • This case highlights the importance of considering mucormycosis in diabetic patients with facial necrosis.
  • Aggressive management including antifungal therapy, surgical intervention, and metabolic control is key.
  • Early and accurate diagnosis is critical for favorable outcomes in rhino-orbito-cerebral mucormycosis.

Related Concept Videos